e-Article
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
Document Type
Article
Author
Wei, J.; Montalvo-Ortiz, W.; Yu, L.; Krasco, A.; Olson, K.; Rizvi, S.; Fiaschi, N.; Coetzee, S.; Wang, F.; Ullman, E.; Ahmed, H.S.; Herlihy, E.; Lee, K.; Havel, L.; Potocky, T.; Ebstein, S.; Frleta, D.; Khatri, A.; Godin, S.; Hamon, S.; Brouwer-Visser, J.; Gorenc, T.; MacDonald, D.; Hermann, A.; Chaudhry, A.; Sirulnik, A.; Olson, W.; Lin, J.; Thurston, G.; Lowy, I.; Murphy, A.J.; Smith, E.; Jankovic, V.; Sleeman, M.A.; Skokos, D.
Source
In: Science Translational Medicine . (Science Translational Medicine, 9 November 2022, 14(670))
Subject
Language
English
ISSN
19466242
19466234
19466234